Updated: January 25, 2026
What Is Breztri Aerosphere? Uses, Dosage, and What You Need to Know in 2026
Author
Peter Daggett

Summarize with AI
- What Are the Active Ingredients in Breztri Aerosphere?
- What Is Breztri Aerosphere Used For?
- What Is the Standard Breztri Aerosphere Dosage?
- How to Use Breztri Aerosphere Correctly
- How Long Does It Take for Breztri to Work?
- Is Breztri a Controlled Substance?
- How Much Does Breztri Cost, and Is There a Generic?
What is Breztri Aerosphere? Learn about this triple-combination COPD and asthma inhaler — its uses, dosage, active ingredients, and what to know in 2026.
Breztri Aerosphere is a prescription inhaler made by AstraZeneca that combines three medications into a single device. It is FDA-approved for the long-term maintenance treatment of chronic obstructive pulmonary disease (COPD) — including chronic bronchitis and emphysema — and as of April 2026, for the maintenance treatment of asthma in patients aged 12 and older. If your doctor has prescribed Breztri, here's everything you need to know about what it is, how to use it, and what to expect.
What Are the Active Ingredients in Breztri Aerosphere?
Breztri Aerosphere contains three active medications that work through complementary mechanisms to control obstructive lung disease:
Budesonide (160 mcg per inhalation): An inhaled corticosteroid (ICS) that reduces inflammation in the airways. Inflammation is a core driver of COPD and asthma symptoms, particularly flare-ups (exacerbations).
Glycopyrrolate (9 mcg per inhalation): A long-acting muscarinic antagonist (LAMA) that relaxes airway smooth muscle by blocking acetylcholine receptors. This opens up narrowed airways to make breathing easier.
Formoterol fumarate (4.8 mcg per inhalation): A long-acting beta2-adrenergic agonist (LABA) that relaxes bronchial smooth muscle by activating beta2 receptors. Lung function improvement can be felt within 5 minutes of the first dose.
Together, this ICS/LAMA/LABA combination is called triple therapy — the most comprehensive type of inhaled maintenance treatment available for obstructive airway disease.
What Is Breztri Aerosphere Used For?
Breztri Aerosphere is indicated for:
Maintenance treatment of COPD in adults (chronic bronchitis and/or emphysema) — FDA-approved July 2020
Maintenance treatment of asthma in patients aged 12 and older — FDA-approved April 28, 2026 (first single-inhaler triple therapy approved for asthma)
Breztri is
NOT intended for:
Relieving sudden breathing problems (it is not a rescue inhaler — you still need a separate short-acting rescue inhaler like albuterol)
Use in children under 12 years of age (safety and effectiveness not established)
What Is the Standard Breztri Aerosphere Dosage?
The recommended dosage of Breztri Aerosphere is:
2 inhalations (puffs) twice daily — 2 puffs in the morning and 2 puffs in the evening
This delivers a total daily dose of 320 mcg budesonide / 18 mcg glycopyrrolate / 9.6 mcg formoterol fumarate
Do not take more than 2 inhalations twice daily — do not use it more frequently or at higher doses than prescribed
How to Use Breztri Aerosphere Correctly
Prime the inhaler before first use: Shake well and release 4 test sprays into the air away from your face. Re-prime with 2 sprays if not used for more than 7 days.
Shake the inhaler well before each use.
Breathe out fully, then close your lips around the mouthpiece.
Press down on the canister as you begin to breathe in slowly. Inhale deeply.
Hold your breath for up to 10 seconds, then breathe out slowly.
Repeat for the second puff.
Rinse your mouth with water and spit (do not swallow) after every use to prevent oral thrush.
How Long Does It Take for Breztri to Work?
Breztri can begin to improve lung function within 5 minutes of the first dose (due to formoterol's rapid onset). However, the full benefit of the triple combination — including reduced exacerbation frequency and sustained inflammation control — typically takes several weeks of consistent daily use to become apparent. Do not stop taking Breztri without talking to your doctor, even if you feel better.
Is Breztri a Controlled Substance?
No. Breztri Aerosphere is not a DEA-scheduled controlled substance. It is a prescription-only medication, but it has no abuse potential and is not subject to the refill restrictions that apply to controlled substances.
How Much Does Breztri Cost, and Is There a Generic?
There is no generic Breztri Aerosphere. Without insurance, the retail price is approximately $670–$930 per inhaler. However, AstraZeneca's Zero Pay program can reduce costs to $0 for eligible commercially insured patients. For the full breakdown of savings options, see our guide on how to save money on Breztri in 2026.
If you're struggling to find Breztri in stock at your pharmacy, medfinder calls pharmacies near you to locate it in stock and texts you the results.
Frequently Asked Questions
Breztri Aerosphere is used for the long-term maintenance treatment of COPD (chronic bronchitis and/or emphysema) in adults, and as of April 2026, for the maintenance treatment of asthma in patients aged 12 and older. It is not a rescue inhaler — it will not relieve sudden breathing problems.
Breztri Aerosphere contains three active medications: budesonide (an inhaled corticosteroid/ICS, 160 mcg per puff), glycopyrrolate (a long-acting muscarinic antagonist/LAMA, 9 mcg per puff), and formoterol fumarate (a long-acting beta2-agonist/LABA, 4.8 mcg per puff).
The recommended dose is 2 puffs (inhalations) twice daily — 2 puffs in the morning and 2 puffs in the evening, for a total of 4 puffs per day. Each 120-inhalation canister provides a 30-day supply at standard dosing.
Breztri can start improving lung function within 5 minutes of the first dose due to formoterol's rapid onset of action. However, the full therapeutic benefit — including consistent exacerbation reduction and inflammation control — typically becomes apparent over several weeks of daily use.
No. Breztri Aerosphere is only available as a brand-name medication. There is no FDA-approved generic version, and patent protection is expected to remain in effect until approximately 2038. Commercially insured patients may qualify for AstraZeneca's Zero Pay program to reduce out-of-pocket costs.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Breztri Aerosphere also looked for:
More about Breztri Aerosphere
31,163 have already found their meds with Medfinder.
Start your search today.





